股本结构
单位：万股
| 公告日期 | 2024-04-12 | 2024-03-20 | 2024-03-20 | 2023-11-22 | 2023-10-26 | 2023-10-26 |
|---|---|---|---|---|---|---|
| 证券总股本 | 158.64 | 170.22 | 127.99 | 137.01 | 137.01 | 127.99 |
| 普通股本 | 15.86 | 17.02 | 12.80 | 13.70 | 13.70 | 12.80 |
| 优先股 | 未披露 | 未披露 | 6.29 | 0.19 | 未披露 | 6.29 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-25 | 2024-03-08 | 2023-12-31 | 2023-10-31 | 2023-10-23 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
，当前存托凭证比例为：0.1
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-12 | 158.64 | 未披露 | 定期报告 | 2024-03-25 |
| 2024-03-20 | 170.22 | 未披露 | 定期报告 | 2024-03-08 |
| 2024-03-20 | 127.99 | 6.29 |
更多>>
From December 31,2022 to December 31,2023
Issuance of common stock in public offerings, net of commissions and issuance costs
Exercise of pre-funded warrants for common stock
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares
Issuance of common stock upon vesting of restricted stock units
|
2023-12-31 |
| 2023-11-22 | 137.01 | 0.19 | 定期报告 | 2023-10-31 |
| 2023-10-26 | 137.01 | 未披露 | 定期报告 | 2023-10-23 |
| 2023-10-26 | 127.99 | 6.29 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock in public offerings, net of commissions and issuance costs
Conversion of CRG loan principal into Series E convertible preferred stock
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares
|
2023-09-30 |
| 2023-09-22 | 128.27 | 未披露 | 定期报告 | 2023-09-22 |
| 2023-09-21 | 121.30 | 未披露 | 定期报告 | 2023-09-21 |
| 2023-09-20 | 111.67 | 未披露 | 定期报告 | 2023-09-20 |
| 2023-09-18 | 71.70 | 未披露 | 定期报告 | 2023-09-15 |
| 2023-09-12 | 71.70 | 未披露 |
更多>>
The Board determined to set the reverse stock split ratio at 1-for-15 (the “Reverse Stock Split”).
|
2023-09-13 |
| 2023-08-17 | 1075.54 | 未披露 | 定期报告 | 2023-08-07 |
| 2023-07-27 | 1082.14 | 未披露 | 定期报告 | 2023-07-21 |
| 2023-07-27 | 933.86 | 6.10 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of pre-funded warrants for common stock
Issuance of common stock in public offerings, net of commissions and issuance costs
|
2023-06-30 |
| 2023-05-10 | 1068.69 | 未披露 | 定期报告 | 2023-05-08 |
| 2023-05-10 | 862.68 | 6.10 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock in public offerings, net of commissions and issuance costs
Exercise of pre-funded warrants for common stock
Issuance of common stock upon vesting of restricted stock units
|
2023-03-31 |
| 2023-03-16 | 861.45 | 未披露 | 定期报告 | 2023-03-10 |
| 2023-03-16 | 783.26 | 6.10 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock in public offerings, net of commissions and issuance costs
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares
Issuance of Series D preferred stock, net of commissions and issuance costs
Exercise of pre-funded warrants for common stock
Issuance of common stock upon vesting of restricted stock units
Conversion of Series D preferred stock into common stock
Issuance of Series A preferred stock to pay dividends
|
2022-12-31 |
| 2022-11-09 | 743.56 | 5.65 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock in public offerings, net of commissions and issuance costs
Exercise of pre-funded warrants for common stock
Issuance of common stock upon vesting of restricted stock units
|
2022-09-30 |
| 2022-08-11 | 704.05 | 未披露 | 定期报告 | 2022-08-08 |
| 2022-08-05 | 634.05 | 5.65 | 定期报告 | 2022-08-03 |
| 2022-08-11 | 608.13 | 5.65 |
更多>>
From March 31, 2022 to June 30, 2022
Conversion of Series D preferred stock into common stock
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock upon vesting of restricted stock units
|
2022-06-30 |
| 2022-05-10 | 567.98 | 未披露 | 定期报告 | 2022-05-06 |
| 2022-05-10 | 545.48 | 5.89 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of Series D preferred stock, net of commissions and issuance costs
Conversion of Series D preferred stock into common stock
Issuance of common stock upon vesting of restricted stock units
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares
|
2022-03-31 |
| 2022-03-22 | 542.88 | 未披露 | 定期报告 | 2022-03-18 |
| 2022-03-14 | 480.00 | 未披露 |
更多>>
Avinger, Inc. today announced that the Company will effect a 1-for-20 reverse stock split of the Company's common stock, which will be effective at 5:00 p.m. Eastern time on Monday, March 14, 2022. The reverse split will reduce the number of shares of the Company's common stock outstanding from approximately 95.6 million to approximately 4.8 million, prior to the issuance of shares relating to the Series D Preferred Stock and warrants.
|
2022-03-15 |
| 2022-01-31 | 9556.52 | 未披露 | 定期报告 | 2022-01-18 |
| 2022-03-22 | 477.83 | 5.65 |
更多>>
From December 31, 2020 to December 31, 2021
Conversion of Series B preferred stock into common stock
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock upon vesting of restricted stock units
Issuance of Series A preferred stock to pay dividends
|
2021-12-31 |
| 2021-11-05 | 9556.40 | 未披露 | 定期报告 | 2021-10-28 |
| 2021-11-12 | 9556.30 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
|
2021-09-30 |
| 2021-08-10 | 9535.30 | 5.23 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
|
2021-06-30 |
| 2021-05-06 | 9535.15 | 5.23 |
更多>>
from December 31, 2020 to March 31, 2021
Conversion of Series B preferred stock into common stock
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
|
2021-03-31 |
| 2021-03-11 | 9529.81 | 未披露 | 定期报告 | 2021-02-26 |
| 2021-02-02 | 9492.11 | 未披露 |
更多>>
1.Securities Offered by the company 10,000,000 shares.
2.The number of shares of common stock in the table above is based on 84,921,079 shares outstanding as of September 30, 2020.
|
2021-02-02 |
| 2021-03-11 | 8492.61 | 5.24 |
更多>>
from December 31, 2019 to December 31, 2020
Issuance of Series A preferred stock to pay dividends
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
|
2020-12-31 |
| 2020-10-26 | 8492.21 | 未披露 | 定期报告 | 2020-10-20 |
| 2020-11-10 | 8492.11 | 4.85 |
更多>>
From December 31, 2019 to September 30, 2020
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
|
2020-09-30 |
| 2020-08-25 | 8356.07 | 未披露 |
更多>>
1.Securities Offered by the company 11,063,830 shares.
2.The number of shares of common stock in the table above is based on 72,496,919 shares outstanding as of August 12, 2020.
|
2020-08-25 |
| 2020-08-20 | 7249.69 | 4.85 | 定期报告 | 2020-08-12 |
| 2020-08-06 | 7012.85 | 未披露 |
更多>>
1.Securities Offered by the company 15,789,474 shares.
2.The number of shares of common stock in the table above is based on 54,339,024 shares outstanding as of July 27, 2020.
|
2020-08-06 |
| 2020-08-03 | 5433.90 | 4.85 | 定期报告 | 2020-07-27 |
| 2020-07-31 | 5133.90 | 4.85 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
|
2020-06-30 |
| 2020-06-26 | 5133.64 | 未披露 |
更多>>
1.Securities offered by the company 20,000,000 shares
2.The number of shares of common stock that will be outstanding after this offering is based on 31,336,355 shares outstanding as of May 31, 2020
|
2020-06-26 |
| 2020-06-15 | 3133.64 | 4.85 | 定期报告 | 2020-05-31 |
| 2020-05-13 | 3133.64 | 未披露 | 定期报告 | 2020-05-08 |
| 2020-05-13 | 1682.14 | 4.85 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
Issuance of common stock in public offerings, net of commissions and issuance costs
|
2020-03-31 |
| 2020-03-06 | 1681.34 | 未披露 | 定期报告 | 2020-03-02 |
| 2020-01-31 | 1679.32 | 未披露 |
更多>>
Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD) today announced the closing of an underwritten public offering of 6,428,572 shares of its common stock at a price of $0.70 per share, for total gross proceeds of approximately $4.5 million, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.
|
2020-01-31 |
| 2020-03-06 | 1036.47 | 4.85 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of Series A preferred stock to pay dividends
Conversion of Series B preferred stock into common stock
Conversion of Series C preferred stock into common stock
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock under officers and directors purchase plan
Exercise of warrants for common stock
Issuance of common stock in August public offerings, net of commissions and issuance costs
|
2019-12-31 |
| 2019-11-05 | 1035.20 | 未披露 | 定期报告 | 2019-11-01 |
| 2019-11-05 | 1034.22 | 4.49 |
更多>>
From June 30, 2019 to September 30, 2019
Issuance of common stock under officers and directors purchase plan
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock in August public offering, net of commissions and issuance costs
|
2019-09-30 |
| 2019-08-26 | 1023.49 | 未披露 | 定期报告 | 2019-08-26 |
| 2019-08-08 | 642.50 | 未披露 | 定期报告 | 2019-08-08 |
| 2019-08-08 | 642.13 | 4.49 |
更多>>
From March 31, 2019 to June 30, 2019
Issuance of common stock under officers and directors purchase plan
Exercises of warrants for common stock
|
2019-06-30 |
| 2019-06-21 | 640.00 | 未披露 |
更多>>
Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that the Company will effect a 1-for-10 reverse stock split of the Company's common stock, which will be effective at 5:00 p.m. Eastern time on Friday, June 21, 2019. The reverse split will reduce the number of shares of the Company's common stock outstanding from approximately 64.2 million to approximately 6.4 million.
|
2019-06-24 |
| 2019-05-08 | 6419.56 | 未披露 | 定期报告 | 2019-05-06 |
| 2019-04-25 | 6418.61 | 未披露 | 定期报告 | 2019-04-15 |
| 2019-05-08 | 6005.30 | 4.49 |
更多>>
from December 31, 2018 to March 31, 2019
Conversion of Series B Preferred Stock into common stock
Conversion of Series C Preferred Stock into common stock
Issuance of Series A preferred stock to pay dividends
Issuance of common stock under officers and directors purchase plan
Exercises of warrants for common stock
|
2019-03-31 |
| 2019-03-06 | 4229.71 | 未披露 | 定期报告 | 2019-03-01 |
| 2019-03-06 | 3492.20 | 4.57 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of common stock under officers’ and directors’ purchase plan
Exercises of warrants for common stock
Common stock issued to a vendor
Issuance of common stock in July public offering, net of commissions and issuance costs
Issuance of Series B Preferred Stock, net of commissions and issuance costs
Conversion of Series B Preferred stock into common stock
Issuance of common stock and Series C Preferred Stock in November public offering, net of commissions and issuance costs
Conversion of Series C Preferred Stock into common stock
Conversion of CRG into Series A Preferred Stock
Issuance of common stock to Lincoln Park
|
2018-12-31 |
| 2018-11-13 | 2345.82 | 未披露 | 定期报告 | 2018-11-08 |
| 2018-11-13 | 1155.41 | 4.35 | 定期报告 | 2018-09-30 |
| 2018-08-13 | 1155.21 | 未披露 | 定期报告 | 2018-08-09 |
| 2018-07-16 | 655.04 | 未披露 |
更多>>
Avinger, Inc. is offering 2,166,180 shares of its common stock pursuant to this prospectus supplement and the accompanying prospectus. Our common stock is quoted on the Nasdaq Capital Market under the symbol "AVGR." The number of shares of our common stock to be outstanding after this offering is based on 4,384,224 shares of our common stock outstanding as of March 31, 2018.
|
2018-07-16 |
| 2018-08-13 | 930.59 | 4.35 | 定期报告 | 2018-06-30 |
| 2018-05-15 | 556.29 | 未披露 | 定期报告 | 2018-05-10 |
| 2018-04-27 | 484.09 | 未披露 | 定期报告 | 2018-04-20 |
| 2018-04-27 | 484.07 | 未披露 | 定期报告 | 2018-04-09 |
| 2018-05-15 | 438.42 | 5.28 | 定期报告 | 2018-03-31 |
| 2018-03-30 | 438.42 | 未披露 | 定期报告 | 2018-03-28 |
| 2018-03-30 | 87.72 | 未披露 |
更多>>
From December 31, 2016 to January 31, 2018
The Company will effect a 1-for-40 reverse stock split of the Company's common stock, which will be effective at 5:00 p.m. Eastern time on Tuesday, January 30, 2018. As of that date, each 40 shares of issued and outstanding common stock and equivalents will be converted into one share of common stock. A new CUSIP number of 053734208 has been assigned to the Company's common stock as a result of the reverse stock split.
Issuance of common stock
Issuance of common stock in public offerings, net of underwriting discount, commissions and issuance costs
|
2018-01-31 |
| 2017-12-28 | 3284.00 | 未披露 | 定期报告 | 2017-12-21 |
| 2017-12-28 | 3259.00 | 未披露 | 定期报告 | 2017-12-11 |
| 2017-11-14 | 3153.91 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-09 | 2391.40 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-05-10 | 2391.34 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-03-15 | 2391.34 | 未披露 | 定期报告 | 2017-03-13 |
| 2017-04-25 | 2387.52 | 未披露 | 定期报告 | 2017-02-28 |
| 2017-03-15 | 2377.60 | 未披露 |
更多>>
from December 31, 2015 to December 31, 2016
Issuance of common stock
Exercise of common stock warrants
Issuance of common stock in Public Offerings, net of underwriting discount, commissions and issuance costs
|
2016-12-31 |
| 2016-11-08 | 2280.42 | 未披露 | 定期报告 | 2016-11-01 |
| 2016-11-08 | 2280.04 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-08-05 | 1284.25 | 未披露 | 定期报告 | 2016-08-01 |
| 2016-08-05 | 1283.61 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-05-09 | 1269.35 | 未披露 | 定期报告 | 2016-03-31 |
| 2016-03-08 | 1269.22 | 未披露 | 定期报告 | 2016-03-07 |
| 2016-03-08 | 1264.35 | 未披露 |
更多>>
From December 31, 2014 to December 31, 2015
Issuance of Series E Convertible Preferred stock, net of issuance costs
Conversion of preferred stock to common stock in connection with the IPO
Exercise of common stock warrants
Additional shares of common stock issued upon the conversion of preferred stock into common stock due to anti-dilution provisions
Issuance of common stock in IPO, net of underwriting discount, commissions and issuance costs
Issuance of common stock related to CRG Loan, net of issuance costs
Issuance of common stock
On January 14, 2015, the Company’s Board of Directors approved an amendment to the Company’s amended and restated certificate of incorporation to effect a 1-for-45 reverse stock split of the Company’s common stock and convertible preferred stock. The reverse stock split was effected on January 28, 2015.
|
2015-12-31 |
| 2015-11-12 | 1262.21 | 未披露 | 定期报告 | 2015-11-02 |
| 2015-11-12 | 1262.07 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-05-13 | 1224.02 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-03-27 | 1222.83 | 未披露 | 定期报告 | 2015-03-26 |
| 2015-01-30 | 1022.98 | 未披露 |
更多>>
a 1-for-45 reverse split of our common stock; the conversion, in accordance with our existing amended and restated certificate of incorporation, of all shares of preferred stock outstanding as of September 30, 2014 into 4,986,823 shares of our common stock upon the closing of this offering;
|
2015-01-30 |
| 2015-03-27 | 24.33 | 526.27 |
更多>>
from December 31, 2013 to January 29, 2015
Issuance of common stock
Issuance of Series E Convertible Preferred stock, net of issuance costs
On January 14, 2015, the Company’s Board of Directors approved an amendment to the Company’s amended and restated certificate of incorporation to effect a 1-for-45 reverse stock split of the Company’s common stock and convertible preferred stock. The reverse stock split was effected on January 28, 2015.
|
2015-01-29 |
| 2014-12-30 | 1093.60 | 19170.74 |
更多>>
from December 31, 2013 to September 30, 2014
Issuance of common stock (unaudited)
Issuance of Series E Convertible Preferred Stock, net of issuance costs (unaudited)
|
2014-09-30 |
From December 31,2022 to December 31,2023
Issuance of common stock in public offerings, net of commissions and issuance costs
Exercise of pre-funded warrants for common stock
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares
Issuance of common stock upon vesting of restricted stock units
From June 30, 2023 to September 30, 2023
Issuance of common stock in public offerings, net of commissions and issuance costs
Conversion of CRG loan principal into Series E convertible preferred stock
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares
The Board determined to set the reverse stock split ratio at 1-for-15 (the “Reverse Stock Split”).
From March 31, 2023 to June 30, 2023
Exercise of pre-funded warrants for common stock
Issuance of common stock in public offerings, net of commissions and issuance costs
From December 31, 2022 to March 31, 2023
Issuance of common stock in public offerings, net of commissions and issuance costs
Exercise of pre-funded warrants for common stock
Issuance of common stock upon vesting of restricted stock units
From December 31, 2021 to December 31, 2022
Issuance of common stock in public offerings, net of commissions and issuance costs
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares
Issuance of Series D preferred stock, net of commissions and issuance costs
Exercise of pre-funded warrants for common stock
Issuance of common stock upon vesting of restricted stock units
Conversion of Series D preferred stock into common stock
Issuance of Series A preferred stock to pay dividends
From June 30, 2022 to September 30, 2022
Issuance of common stock in public offerings, net of commissions and issuance costs
Exercise of pre-funded warrants for common stock
Issuance of common stock upon vesting of restricted stock units
From March 31, 2022 to June 30, 2022
Conversion of Series D preferred stock into common stock
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock upon vesting of restricted stock units
From December 31, 2021 to March 31, 2022
Issuance of Series D preferred stock, net of commissions and issuance costs
Conversion of Series D preferred stock into common stock
Issuance of common stock upon vesting of restricted stock units
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares
Avinger, Inc. today announced that the Company will effect a 1-for-20 reverse stock split of the Company's common stock, which will be effective at 5:00 p.m. Eastern time on Monday, March 14, 2022. The reverse split will reduce the number of shares of the Company's common stock outstanding from approximately 95.6 million to approximately 4.8 million, prior to the issuance of shares relating to the Series D Preferred Stock and warrants.
From December 31, 2020 to December 31, 2021
Conversion of Series B preferred stock into common stock
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock upon vesting of restricted stock units
Issuance of Series A preferred stock to pay dividends
From June 30, 2021 to September 30, 2021
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
From March 31, 2021 to June 30, 2021
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
from December 31, 2020 to March 31, 2021
Conversion of Series B preferred stock into common stock
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
1.Securities Offered by the company 10,000,000 shares.
2.The number of shares of common stock in the table above is based on 84,921,079 shares outstanding as of September 30, 2020.
from December 31, 2019 to December 31, 2020
Issuance of Series A preferred stock to pay dividends
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
From December 31, 2019 to September 30, 2020
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
1.Securities Offered by the company 11,063,830 shares.
2.The number of shares of common stock in the table above is based on 72,496,919 shares outstanding as of August 12, 2020.
1.Securities Offered by the company 15,789,474 shares.
2.The number of shares of common stock in the table above is based on 54,339,024 shares outstanding as of July 27, 2020.
From March 31, 2020 to June 30, 2020
Issuance of common stock in public offerings, net of commissions and issuance costs
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
1.Securities offered by the company 20,000,000 shares
2.The number of shares of common stock that will be outstanding after this offering is based on 31,336,355 shares outstanding as of May 31, 2020
From December 31, 2019 to March 31, 2020
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units
Issuance of common stock in public offerings, net of commissions and issuance costs
Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD) today announced the closing of an underwritten public offering of 6,428,572 shares of its common stock at a price of $0.70 per share, for total gross proceeds of approximately $4.5 million, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.
from December 31, 2018 to December 31, 2019
Issuance of Series A preferred stock to pay dividends
Conversion of Series B preferred stock into common stock
Conversion of Series C preferred stock into common stock
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock under officers and directors purchase plan
Exercise of warrants for common stock
Issuance of common stock in August public offerings, net of commissions and issuance costs
From June 30, 2019 to September 30, 2019
Issuance of common stock under officers and directors purchase plan
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock in August public offering, net of commissions and issuance costs
From March 31, 2019 to June 30, 2019
Issuance of common stock under officers and directors purchase plan
Exercises of warrants for common stock
Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that the Company will effect a 1-for-10 reverse stock split of the Company's common stock, which will be effective at 5:00 p.m. Eastern time on Friday, June 21, 2019. The reverse split will reduce the number of shares of the Company's common stock outstanding from approximately 64.2 million to approximately 6.4 million.
from December 31, 2018 to March 31, 2019
Conversion of Series B Preferred Stock into common stock
Conversion of Series C Preferred Stock into common stock
Issuance of Series A preferred stock to pay dividends
Issuance of common stock under officers and directors purchase plan
Exercises of warrants for common stock
from December 31, 2017 to December 31, 2018
Issuance of common stock under officers’ and directors’ purchase plan
Exercises of warrants for common stock
Common stock issued to a vendor
Issuance of common stock in July public offering, net of commissions and issuance costs
Issuance of Series B Preferred Stock, net of commissions and issuance costs
Conversion of Series B Preferred stock into common stock
Issuance of common stock and Series C Preferred Stock in November public offering, net of commissions and issuance costs
Conversion of Series C Preferred Stock into common stock
Conversion of CRG into Series A Preferred Stock
Issuance of common stock to Lincoln Park
Avinger, Inc. is offering 2,166,180 shares of its common stock pursuant to this prospectus supplement and the accompanying prospectus. Our common stock is quoted on the Nasdaq Capital Market under the symbol "AVGR." The number of shares of our common stock to be outstanding after this offering is based on 4,384,224 shares of our common stock outstanding as of March 31, 2018.
From December 31, 2016 to January 31, 2018
The Company will effect a 1-for-40 reverse stock split of the Company's common stock, which will be effective at 5:00 p.m. Eastern time on Tuesday, January 30, 2018. As of that date, each 40 shares of issued and outstanding common stock and equivalents will be converted into one share of common stock. A new CUSIP number of 053734208 has been assigned to the Company's common stock as a result of the reverse stock split.
Issuance of common stock
Issuance of common stock in public offerings, net of underwriting discount, commissions and issuance costs
from December 31, 2015 to December 31, 2016
Issuance of common stock
Exercise of common stock warrants
Issuance of common stock in Public Offerings, net of underwriting discount, commissions and issuance costs
From December 31, 2014 to December 31, 2015
Issuance of Series E Convertible Preferred stock, net of issuance costs
Conversion of preferred stock to common stock in connection with the IPO
Exercise of common stock warrants
Additional shares of common stock issued upon the conversion of preferred stock into common stock due to anti-dilution provisions
Issuance of common stock in IPO, net of underwriting discount, commissions and issuance costs
Issuance of common stock related to CRG Loan, net of issuance costs
Issuance of common stock
On January 14, 2015, the Company’s Board of Directors approved an amendment to the Company’s amended and restated certificate of incorporation to effect a 1-for-45 reverse stock split of the Company’s common stock and convertible preferred stock. The reverse stock split was effected on January 28, 2015.
a 1-for-45 reverse split of our common stock; the conversion, in accordance with our existing amended and restated certificate of incorporation, of all shares of preferred stock outstanding as of September 30, 2014 into 4,986,823 shares of our common stock upon the closing of this offering;
from December 31, 2013 to January 29, 2015
Issuance of common stock
Issuance of Series E Convertible Preferred stock, net of issuance costs
On January 14, 2015, the Company’s Board of Directors approved an amendment to the Company’s amended and restated certificate of incorporation to effect a 1-for-45 reverse stock split of the Company’s common stock and convertible preferred stock. The reverse stock split was effected on January 28, 2015.
from December 31, 2013 to September 30, 2014
Issuance of common stock (unaudited)
Issuance of Series E Convertible Preferred Stock, net of issuance costs (unaudited)